Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Oct 11 - Oct 16
Each one has research behind it, but the devil lives in the details
These results are initially surprising as GIP contributes more than GLP-1 to the incretin effect in healthy individuals (Manchanda et al
Technical Information Compound Name: Tirzepatide Peptide Classification: Dual GIP/GLP-1 Receptor Agonist Molecular Formula: CHNO Appearance: White to off-white lyophilized powder Solubility: Typically soluble in bacteriostatic water or suitable research-grade diluents Research Category: Metabolic and incretin-pathway research peptide Common Research Areas GIP and GLP-1 receptor signaling Glucose-homeostasis investigations Appetite and satiety-related research Adipose and metabolic-regulation studies Cardiometabolic and obesity-related research Endocrine and energy-balance pathway investigations For Laboratory and Research Use Only Not for human consumption or therapeutic use
If you believe you injected too much or too little medication, contact your healthcare provider as soon as possible
Availabel at Accessed 01/17/2023
US$ 26.14
US$ 25.45
US$ 23.98
US$ 27.38
